-
公开(公告)号:NO905411L
公开(公告)日:1991-06-17
申请号:NO905411
申请日:1990-12-14
Applicant: HOECHST AG
Inventor: THORWART WERNER , SCHLEUERBACH RUDOLF , BARTLETT ROBERT , WEITHMANN KLAUS ULRICH
IPC: A61K31/425 , A61K31/426 , A61P29/00 , A61P37/00 , C07D277/24 , C07D277/26 , C07D277/28 , C07D277/30 , C07D417/06 , C07D417/12 , C07D277/22
Abstract: Novel substituted thiazoles of the formula I (I) in which R1 is a saturated or unsaturated, straight-chain or branched C1-C5-alkyl group, R2 is a hydrogen atom or an alkyl radical having 1 to 3 carbon atoms, A is an intermediate chain of the formula -(CH2)n-Y-CR3R4-; -CH=CR3-(CH2)m- or -CH=N-O-(CH2)n- where Y is a single bond, an oxygen or sulfur atom or a carbonyl group, R3 and R4 are identical or different and are a hydrogen atom or an alkyl radical having up to two carbon atoms, m is a number from 0 to 3 and n is a number from 1 to 4, and Z is a tetrazole or CN group, or a radical of the formula X is a hydroxyl group or a radical of the formula R5O- or R6R7N-, where R5 is a straight-chain or branched C1-C4-alkyl radical which is optionally substituted by hydroxyl, C1-C3-alkoxy or C1-C3-alkylamino, R6 and R7 are identical or different and are a hydrogen atom, a straight-chain or branched C1-C6-alkyl radicall or, for the case in which R6 is a hydrogen atom or a C1-C4-alkyl radical, R7 is a hydroxyl, a C1-C3-alkoxy or a tetrazol-5-yl group or X, together with the structural element -A-(C=O)-, is a radical of the formula II (II) where R8 is a hydrogen atom, a C1-C3-alkyl radical or a C1-C3-alkoxy radical, and physiologically tolerable salts of such compounds of the formula I in which X is a hydroxyl or hydroxyamino group, are prepared by various processes. They are preferably suitable for the treatment and prophylaxis of inflammatory diseases - in particular inflammatory rheumatic diseases.
-
公开(公告)号:CA2249348C
公开(公告)日:2006-10-03
申请号:CA2249348
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: THEN JOHANN , BARTLETT ROBERT
IPC: A61K31/42 , A61K31/00 , A61K31/275 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: Combination preparation, comprising 5-methyl-4'-trifluoromethyl-4- isoxazolecarboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3- hydroxycrotonamide A solid preparation, comprising 5-methyl-4'-trifluoromethyl-4- isoxazolecarboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3- hydroxycrotonamide is suitable for treating immunological diseases.
-
公开(公告)号:NZ331933A
公开(公告)日:2000-06-23
申请号:NZ33193397
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: A solid preparation, containing 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide of formula I, suitable for use in the treatment of immunological conditions.
-
公开(公告)号:NO984343A
公开(公告)日:1998-09-18
申请号:NO984343
申请日:1998-09-18
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
CPC classification number: C07D261/18 , A61K31/42 , A61K31/275 , A61K2300/00
-
35.
公开(公告)号:CA2191827A1
公开(公告)日:1997-06-05
申请号:CA2191827
申请日:1996-12-02
Applicant: HOECHST AG
Inventor: KIRSCHBAUM BERND , MUELLNER STEFAN , BARTLETT ROBERT
IPC: C12N15/09 , A61K38/00 , C07K14/00 , C07K14/47 , C12N5/10 , C12N9/90 , C12N15/55 , C12Q1/68 , C12Q1/6823 , C12Q1/6886 , C12N15/52 , C12N9/00 , G01N33/53
Abstract: Protein which binds ATP and nucleic acid and possesses putative helicase and ATPase properties The present invention relates to the identification and molecular-biological and biochemical characterization of a protein which binds ATP and nucleic acid and possesses putative helicase and ATPase properties, and to processes for its preparation and use in pharmacologically relevant test and assay systems.
-
公开(公告)号:DE59010701D1
公开(公告)日:1997-05-22
申请号:DE59010701
申请日:1990-10-24
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , KAEMMERER FRIEDRICH-JOHANNES
IPC: C07C233/58 , A61K31/00 , A61K31/16 , A61K31/165 , A61K31/166 , A61K31/275 , A61K31/36 , A61K31/395 , A61K31/415 , A61K31/416 , A61K31/4184 , A61K31/42 , A61K31/422 , A61K31/425 , A61K31/426 , A61K31/428 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/4427 , A61K31/4439 , A61K31/496 , A61K31/505 , A61K31/506 , A61P35/00 , A61P35/02 , C07C237/16 , C07C255/21 , C07C255/23 , C07C255/41 , C07C317/40 , C07D211/16 , C07D211/40 , C07D213/00 , C07D213/75 , C07D231/56 , C07D235/30 , C07D235/32 , C07D239/30 , C07D239/42 , C07D261/08 , C07D261/18 , C07D277/20 , C07D277/30 , C07D277/38 , C07D277/46 , C07D277/68 , C07D277/82 , C07D295/16 , C07D317/66 , C07D413/12
Abstract: Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use Isoxazole-4-carboxamide derivatives and hydroxyalkylidene-cyanoacetamide derivatives are suitable for the treatment of carcinoses. These compounds can be prepared by known processes. Some of the compounds are novel and are additionally suitable for the treatment of rheumatic disorders.
-
公开(公告)号:PT96181A
公开(公告)日:1991-09-30
申请号:PT9618190
申请日:1990-12-13
Applicant: HOECHST AG
Inventor: THORWART WERNER , SCHLEYERBACH RUDOLF , BARTLETT ROBERT , WEITHAMANN KLANS ULRICH
IPC: A61K31/425 , A61K31/426 , A61P29/00 , A61P37/00 , C07D277/24 , C07D277/26 , C07D277/28 , C07D277/30 , C07D417/06 , C07D417/12 , C07D , A61K
Abstract: Novel substituted thiazoles of the formula I (I) in which R1 is a saturated or unsaturated, straight-chain or branched C1-C5-alkyl group, R2 is a hydrogen atom or an alkyl radical having 1 to 3 carbon atoms, A is an intermediate chain of the formula -(CH2)n-Y-CR3R4-; -CH=CR3-(CH2)m- or -CH=N-O-(CH2)n- where Y is a single bond, an oxygen or sulfur atom or a carbonyl group, R3 and R4 are identical or different and are a hydrogen atom or an alkyl radical having up to two carbon atoms, m is a number from 0 to 3 and n is a number from 1 to 4, and Z is a tetrazole or CN group, or a radical of the formula X is a hydroxyl group or a radical of the formula R5O- or R6R7N-, where R5 is a straight-chain or branched C1-C4-alkyl radical which is optionally substituted by hydroxyl, C1-C3-alkoxy or C1-C3-alkylamino, R6 and R7 are identical or different and are a hydrogen atom, a straight-chain or branched C1-C6-alkyl radicall or, for the case in which R6 is a hydrogen atom or a C1-C4-alkyl radical, R7 is a hydroxyl, a C1-C3-alkoxy or a tetrazol-5-yl group or X, together with the structural element -A-(C=O)-, is a radical of the formula II (II) where R8 is a hydrogen atom, a C1-C3-alkyl radical or a C1-C3-alkoxy radical, and physiologically tolerable salts of such compounds of the formula I in which X is a hydroxyl or hydroxyamino group, are prepared by various processes. They are preferably suitable for the treatment and prophylaxis of inflammatory diseases - in particular inflammatory rheumatic diseases.
-
公开(公告)号:CA2032282A1
公开(公告)日:1991-06-16
申请号:CA2032282
申请日:1990-12-14
Applicant: HOECHST AG
Inventor: THORWART WERNER , SCHLEYERBACH RUDOLF , BARTLETT ROBERT , WEITHMANN KLAUS U
IPC: A61K31/425 , A61K31/426 , A61P29/00 , A61P37/00 , C07D277/24 , C07D277/26 , C07D277/28 , C07D277/30 , C07D417/06 , C07D417/12 , C07D417/02
Abstract: - 1 - HOE 89/F 393 of the disclosure: Novel 2-substituted 4-(3-alky1-5-tert.-butyl-4-hydroxy-phenyl)thiazoles, processes for their preparation, pharmaceuticals containing them and their use Novel substituted thiazoles of the formula I (I) in which R1 is a saturated or unsaturated, straight-chain or branched Cl-C5-alkyl group, R2 is a hydrogen atom or an alkyl radical having 1 to 3 carbon atoms, A is an intermediate chain of the formula -(CH2)n-Y-CR3R4-;-CH=CR3-(CH2)m- or -CH=N-O-(CH2)n-where Y is a single bond, an oxygen or sulfur atom or a carbonyl group, R3 and R4 are identical or different and are a hydrogen atom or an alkyl radical having up to two carbon atoms, m is a number from 0 to 3 and n is a number from 1 to 4, and Z is a tetrazole or CN group, or a radical of the formula X is a hydroxyl group or a radical of the formula R5O or R6R7N-, where R5 is a straight-chain or branched ClC4-alkyl radical which is optionally substituted by hydroxyl, C1-C3-alkoxy or Cl-C3-alkylamino, R6 and R7 are identical or different and are a hydrogen atom, a straiqht-chain or branched Cl-C6-alkyl radical or, for the case in which R6 is a hydrogen atom or a Cl-C4-alkyl radical, R7 is a hydroxyl, a Cl-C3-alkoxy or a tetrazol-5-yl group or X, together with the structural element -A-(C=O)-, is a radical of the formula II (II) where R8 is a hydrogen atom, a Cl-C3-alkyl radical or a C1-C3-alkoxy radical, and physiologically tolerable salts of such compounds of the formula I in which X is a hydroxyl or hydroxyamino group, are prepared by various processes. They are preferably suitable for the treatment and prophylaxis of inflammatory diseases - in particular inflammatory rheumatic diseases.
-
公开(公告)号:NO905411D0
公开(公告)日:1990-12-14
申请号:NO905411
申请日:1990-12-14
Applicant: HOECHST AG
Inventor: THORWART WERNER , SCHLEUERBACH RUDOLF , BARTLETT ROBERT , WEITHMANN KLAUS ULRICH
IPC: A61K31/425 , A61K31/426 , A61P29/00 , A61P37/00 , C07D277/24 , C07D277/26 , C07D277/28 , C07D277/30 , C07D417/06 , C07D417/12 , C07D277/00
Abstract: Novel substituted thiazoles of the formula I (I) in which R1 is a saturated or unsaturated, straight-chain or branched C1-C5-alkyl group, R2 is a hydrogen atom or an alkyl radical having 1 to 3 carbon atoms, A is an intermediate chain of the formula -(CH2)n-Y-CR3R4-; -CH=CR3-(CH2)m- or -CH=N-O-(CH2)n- where Y is a single bond, an oxygen or sulfur atom or a carbonyl group, R3 and R4 are identical or different and are a hydrogen atom or an alkyl radical having up to two carbon atoms, m is a number from 0 to 3 and n is a number from 1 to 4, and Z is a tetrazole or CN group, or a radical of the formula X is a hydroxyl group or a radical of the formula R5O- or R6R7N-, where R5 is a straight-chain or branched C1-C4-alkyl radical which is optionally substituted by hydroxyl, C1-C3-alkoxy or C1-C3-alkylamino, R6 and R7 are identical or different and are a hydrogen atom, a straight-chain or branched C1-C6-alkyl radicall or, for the case in which R6 is a hydrogen atom or a C1-C4-alkyl radical, R7 is a hydroxyl, a C1-C3-alkoxy or a tetrazol-5-yl group or X, together with the structural element -A-(C=O)-, is a radical of the formula II (II) where R8 is a hydrogen atom, a C1-C3-alkyl radical or a C1-C3-alkoxy radical, and physiologically tolerable salts of such compounds of the formula I in which X is a hydroxyl or hydroxyamino group, are prepared by various processes. They are preferably suitable for the treatment and prophylaxis of inflammatory diseases - in particular inflammatory rheumatic diseases.
-
公开(公告)号:FI906141A0
公开(公告)日:1990-12-13
申请号:FI906141
申请日:1990-12-13
Applicant: HOECHST AG
Inventor: THORWART WERNER , SCHLEYERBACH RUDOLF , BARTLETT ROBERT , WEITHMANN KLAUS ULRICH
IPC: A61K31/425 , A61K31/426 , A61P29/00 , A61P37/00 , C07D277/24 , C07D277/26 , C07D277/28 , C07D277/30 , C07D417/06 , C07D417/12 , C07D
Abstract: Novel substituted thiazoles of the formula I (I) in which R1 is a saturated or unsaturated, straight-chain or branched C1-C5-alkyl group, R2 is a hydrogen atom or an alkyl radical having 1 to 3 carbon atoms, A is an intermediate chain of the formula -(CH2)n-Y-CR3R4-; -CH=CR3-(CH2)m- or -CH=N-O-(CH2)n- where Y is a single bond, an oxygen or sulfur atom or a carbonyl group, R3 and R4 are identical or different and are a hydrogen atom or an alkyl radical having up to two carbon atoms, m is a number from 0 to 3 and n is a number from 1 to 4, and Z is a tetrazole or CN group, or a radical of the formula X is a hydroxyl group or a radical of the formula R5O- or R6R7N-, where R5 is a straight-chain or branched C1-C4-alkyl radical which is optionally substituted by hydroxyl, C1-C3-alkoxy or C1-C3-alkylamino, R6 and R7 are identical or different and are a hydrogen atom, a straight-chain or branched C1-C6-alkyl radicall or, for the case in which R6 is a hydrogen atom or a C1-C4-alkyl radical, R7 is a hydroxyl, a C1-C3-alkoxy or a tetrazol-5-yl group or X, together with the structural element -A-(C=O)-, is a radical of the formula II (II) where R8 is a hydrogen atom, a C1-C3-alkyl radical or a C1-C3-alkoxy radical, and physiologically tolerable salts of such compounds of the formula I in which X is a hydroxyl or hydroxyamino group, are prepared by various processes. They are preferably suitable for the treatment and prophylaxis of inflammatory diseases - in particular inflammatory rheumatic diseases.
-
-
-
-
-
-
-
-
-